BioAtla OverviewBioAtla EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BCAB.
Quarterly EBIT
-$9.31M
↑ 47.16% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$49.18M
↑ 26.7% YoY
Trailing 12 months ending Mar 31, 2026
BioAtla OverviewEBIT (Earnings Before Interest and Taxes) analysis for BCAB.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026